10.09.2019
- The quality specifications of biopharmaceuticals are enormous and require a long list of time-consuming analytics. A big disadvantage of these analytics so far was, that their...
10.09.2019
- Is it possible to learn from other industries or are we doomed to repeat the same mistakes in the pharma sector? Not long ago, I came across a Forbes article which described how...
02.07.2019
- Swiss fine chemicals producer and drug developer Lonza has signed a binding agreement to acquire a sterile drug product fill & finish plant from Novartis, the first such facility...
21.05.2019
- Novartis may be close to a billion-dollar settlement with the US government to resolve a whistleblower lawsuit accusing the Swiss pharmaceuticals giant of bribing doctors to boost...
17.05.2019
- US protein engineering company Codexis has signed a platform agreement with Novartis, granting the Swiss pharmaceutical producer a non-exclusive license to its proprietary...
13.05.2019
- To lighten its debt burden of more than $30 billion resulting from last year’s acquisition of Shire, Japanese pharma giant Takeda is selling Shire’s dry-eye drug Xiidra to...
17.04.2019
- Swiss drugmaker Novartis and US biopharma Amgen are embroiled in a legal dispute regarding their collaboration on migraine prevention drug Aimovig. Novartis has filed a complaint...
08.04.2019
- The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious...